{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:02:43Z","timestamp":1793224963339,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Academic Enhancement Support Program of Hainan Medical University","award":["XSTS2025182"],"award-info":[{"award-number":["XSTS2025182"]}]},{"name":"Hainan Provincial Natural Science Foundation of China","award":["No. 2019RC229"],"award-info":[{"award-number":["No. 2019RC229"]}]},{"name":"Hainan Provincial Natural Science Foundation of China","award":["No. 20152023"],"award-info":[{"award-number":["No. 20152023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11418-026-02013-w","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T19:03:46Z","timestamp":1774811026000},"page":"513-529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recent advances in progress of natural anticoagulant active substances"],"prefix":"10.1007","volume":"80","author":[{"given":"Meilian","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0715-6297","authenticated-orcid":false,"given":"Shuojin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"issue":"9","key":"2013_CR1","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","volume":"118","author":"AM Wendelboe","year":"2016","unstructured":"Wendelboe AM, Raskob GE (2016) Global burden of thrombosis. Circ Res 118(9):1340\u20131347","journal-title":"Circ Res"},{"issue":"3","key":"2013_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/jth.12124","volume":"11","author":"MV Huisman","year":"2013","unstructured":"Huisman MV, Klok FA (2013) Diagnostic management of acute deep vein thrombosis and pulmonary embolism. J Thromb Haemost 11(3):412\u2013422","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2013_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrcardio.2011.91","volume":"8","author":"G Lippi","year":"2011","unstructured":"Lippi G, Franchini M, Targher G (2011) Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol 8(9):502\u2013512","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"2013_CR4","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.21037\/jtd.2018.03.95","volume":"10","author":"P Fan","year":"2018","unstructured":"Fan P, Gao Y, Zheng M, Xu T, Schoenhagen P, Jin Z (2018) Recent progress and market analysis of anticoagulant drugs. J Thorac Dis 10(3):2011\u20132025","journal-title":"J Thorac Dis"},{"issue":"1","key":"2013_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrd3185","volume":"10","author":"E Perzborn","year":"2011","unstructured":"Perzborn E, Roehrig S, Straub A, Kubitza D, Misselwitz F (2011) The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor. Nat Rev Drug Discov 10(1):61\u201375","journal-title":"Nat Rev Drug Discov"},{"issue":"22","key":"2013_CR6","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM199105303242206","volume":"324","author":"JA Oates","year":"1991","unstructured":"Oates JA, Wood AJJ, Hirsh J (1991) Heparin. N Engl J Med 324(22):1565\u20131574","journal-title":"N Engl J Med"},{"issue":"9","key":"2013_CR7","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/S0735-1097(03)00416-9","volume":"41","author":"J Hirsh","year":"2003","unstructured":"Hirsh J, Fuster V, Ansell J, Halperin JL (2003) American heart Association, American college of cardiology foundation guide to warfarin therapy. J Am Acad Coll Cardiol 41(9):1633\u20131652","journal-title":"J Am Acad Coll Cardiol"},{"issue":"1","key":"2013_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5811\/westjem.2014.12.22933","volume":"16","author":"K Harter","year":"2015","unstructured":"Harter K, Levine M, Henderson SO (2015) Anticoagulation drug therapy: a review. West J Emerg Med 16(1):11\u201317","journal-title":"West J Emerg Med"},{"issue":"7368","key":"2013_CR9","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/bmj.325.7368.828","volume":"325","author":"DA Fitzmaurice","year":"2002","unstructured":"Fitzmaurice DA (2002) Bleeding risks of antithrombotic therapy. BMJ 325(7368):828\u2013831","journal-title":"BMJ"},{"issue":"8","key":"2013_CR10","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1021\/acs.jmedchem.2c02130","volume":"66","author":"Z Xie","year":"2023","unstructured":"Xie Z, Meng Z, Yang X, Duan Y, Wang Q, Liao C (2023) Factor XIa inhibitors in anticoagulation therapy: recent advances and perspectives. J Med Chem 66(8):5332\u20135363","journal-title":"J Med Chem"},{"issue":"9215","key":"2013_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(00)02225-X","volume":"355","author":"B Dahlb\u00e4ck","year":"2000","unstructured":"Dahlb\u00e4ck B (2000) Blood coagulation. Lancet 355(9215):1627\u20131632","journal-title":"Lancet"},{"issue":"7181","key":"2013_CR12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nature06797","volume":"451","author":"N Mackman","year":"2008","unstructured":"Mackman N (2008) Triggers, targets and treatments for thrombosis. Nature 451(7181):914\u2013918","journal-title":"Nature"},{"issue":"11","key":"2013_CR13","first-page":"785","volume":"38","author":"M Koupenova","year":"2017","unstructured":"Koupenova M, Kehrel BE, Corkrey HA, Freedman JE (2017) Thrombosis and platelets: an update. Eur Heart J 38(11):785\u2013791","journal-title":"Eur Heart J"},{"issue":"1","key":"2013_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1182\/blood-2008-01-077909","volume":"112","author":"B Dahlb\u00e4ck","year":"2008","unstructured":"Dahlb\u00e4ck B (2008) Advances in Understanding pathogenic mechanisms of thrombophilic disorders. Blood 112(1):19\u201327","journal-title":"Blood"},{"key":"2013_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/jth.12229","volume":"11","author":"RAS Ari\u00ebns","year":"2013","unstructured":"Ari\u00ebns RAS (2013) Fibrin(ogen) and thrombotic disease. J Thromb Haemost 11:294\u2013305","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2013_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/ddc3010011","volume":"3","author":"N Chaachouay","year":"2024","unstructured":"Chaachouay N, Zidane L (2024) Plant-Derived natural products: A source for drug discovery and development. DDC 3(1):184\u2013207","journal-title":"DDC"},{"issue":"1\u20133","key":"2013_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejphar.2009.06.065","volume":"625","author":"S Mandal","year":"2009","unstructured":"Mandal S, Moudgil Mn, Mandal SK (2009) Rational drug design. Eur J Pharmacol 625(1\u20133):90\u2013100","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"2013_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1055\/s-2002-35292","volume":"28","author":"F Markwardt","year":"2002","unstructured":"Markwardt F (2002) Hirudin as alternative Anticoagulant-A historical review. Semin Thromb Hemost 28(5):405\u2013414","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2013_CR19","first-page":"3","volume":"21","author":"WS Fields","year":"1991","unstructured":"Fields WS (1991) The history of leeching and Hirudin. Pathophysiol Haemos Thromb 21(1):3\u201310","journal-title":"Pathophysiol Haemos Thromb"},{"issue":"2","key":"2013_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/02648725.2018.1506898","volume":"34","author":"J Zhang","year":"2018","unstructured":"Zhang J, Lan N (2018) Hirudin variants production by genetic engineered microbial factory. Biotechnol Genet Eng Rev 34(2):261\u2013280","journal-title":"Biotechnol Genet Eng Rev"},{"key":"2013_CR21","doi-asserted-by":"publisher","first-page":"660757","DOI":"10.3389\/fphar.2021.660757","volume":"12","author":"C Junren","year":"2021","unstructured":"Junren C, Xiaofang X, Huiqiong Z, Gangmin L, Yanpeng Y, Xiaoyu C, Yuqing G, Yanan L et al (2021) Pharmacological activities and mechanisms of Hirudin and its Derivatives-A review. Front Pharmacol 12:660757","journal-title":"Front Pharmacol"},{"key":"2013_CR22","doi-asserted-by":"publisher","first-page":"100078","DOI":"10.1016\/j.pscia.2025.100078","volume":"3","author":"Z Bao","year":"2025","unstructured":"Bao Z, Qi X, Zhu S, Zhang M, Liu X, Chen P, Zhang L, Geng T et al (2025) Recent progress on formulations of Hirudin. Pharm Sci Adv 3:100078","journal-title":"Pharm Sci Adv"},{"issue":"41","key":"2013_CR23","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1126\/sciadv.abc0382","volume":"6","author":"XAO Xu","year":"2020","unstructured":"Xu XAO, Huang X, Zhang Y, Shen S, Feng Z, Dong H, Zhang C, Mo RA-O (2020) Self-regulated Hirudin delivery for anticoagulant therapy. Sci Adv 6(41):2375\u20132548","journal-title":"Sci Adv"},{"issue":"5","key":"2013_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","volume":"19","author":"N Mackman","year":"2020","unstructured":"Mackman N, Bergmeier W, Stouffer GA, Weitz JI (2020) Therapeutic strategies for thrombosis: new targets and approaches. Nat Rev Drug Discov 19(5):333\u2013352","journal-title":"Nat Rev Drug Discov"},{"key":"2013_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.procbio.2018.11.022","volume":"77","author":"SC Wang","year":"2019","unstructured":"Wang SC, Wang XD, Teng XN, Xiu ZL (2019) Chemical modification of Recombinant Hirudin with palmitic acid in mixed aqueous-organic solutions. Process Biochem 77:85\u201392","journal-title":"Process Biochem"},{"issue":"11","key":"2013_CR26","doi-asserted-by":"publisher","first-page":"e2314349121","DOI":"10.1073\/pnas.2314349121","volume":"121","author":"X Tian","year":"2024","unstructured":"Tian X, Feng M, Wei X, Cheng C, He K, Jiang T, He B, Gu Z (2024) In situ formed depot of elastin-like polypeptide-hirudin fusion protein for long-acting antithrombotic therapy. Proc Natl Acad Sci U S A 121(11):e2314349121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2013_CR27","doi-asserted-by":"publisher","first-page":"119869","DOI":"10.1016\/j.ijpharm.2020.119869","volume":"589","author":"HH Han","year":"2020","unstructured":"Han HH, Zhang HT, Wang R, Yan Y, Liu X, Wang Y, Zhu Y, Wang JC (2020) Improving long circulation and procoagulant platelet targeting by engineering of Hirudin prodrug. Int J Pharm 589:119869","journal-title":"Int J Pharm"},{"key":"2013_CR28","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3389\/fphar.2020.01132","volume":"11","author":"KCF Bordon","year":"2020","unstructured":"Bordon KCF, Cologna CT, Fornari Baldo EC, Pinheiro J\u00fanior EL, Cerni FA, Amorim FG, Anjolette FAP, Cordeiro FA et al (2020) From animal poisons and venoms to medicines: Achievements, challenges and perspectives in drug discovery. Front Pharmacol 11:1132","journal-title":"Front Pharmacol"},{"issue":"11","key":"2013_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/toxins10110474","volume":"10","author":"A Munawar","year":"2018","unstructured":"Munawar A, Ali SA, Akrem A, Betzel C (2018) Snake venom peptides: tools of biodiscovery. Toxins 10(11):474","journal-title":"Toxins"},{"issue":"10","key":"2013_CR30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/biom13101539","volume":"13","author":"E Messadi","year":"2023","unstructured":"Messadi E (2023) Snake venom components as therapeutic drugs in ischemic heart disease. Biomolecules 13(10):1539","journal-title":"Biomolecules"},{"issue":"5","key":"2013_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/toxins11050303","volume":"11","author":"P Lazarovici","year":"2019","unstructured":"Lazarovici P, Marcinkiewicz C, Lelkes PI (2019) From snake venom\u2019s disintegrins and C-Type lectins to Anti-Platelet drugs. Toxins 11(5):303","journal-title":"Toxins"},{"issue":"8","key":"2013_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/toxins17080371","volume":"17","author":"E Kim","year":"2025","unstructured":"Kim E, Hwang DH, Mohan Prakash RL, Asirvatham RD, Lee H, Heo Y, Munawir A, Seyedian R et al (2025) Animal venom in modern medicine: A review of therapeutic applications. Toxins 17(8):371","journal-title":"Toxins"},{"key":"2013_CR33","doi-asserted-by":"publisher","first-page":"111527","DOI":"10.1016\/j.biopha.2021.111527","volume":"138","author":"J Huang","year":"2021","unstructured":"Huang J, Song W, Hua H, Yin X, Huang F, Alolga RN (2021) Antithrombotic and anticoagulant effects of a novel protein isolated from the venom of the Deinagkistrodon Acutus snake. Biomed Pharmacother 138:111527","journal-title":"Biomed Pharmacother"},{"key":"2013_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.toxlet.2020.05.014","volume":"330","author":"CN Zdenek","year":"2020","unstructured":"Zdenek CN, Youngman NJ, Hay C, Dobson J, Dunstan N, Allen L, Milanovic L, Fry BG (2020) Anticoagulant activity of black snake (Elapidae: Pseudechis) venoms: Mechanisms, potency, and antivenom efficacy. Toxicol Lett 330:176\u2013184","journal-title":"Toxicol Lett"},{"key":"2013_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.toxicon.2020.09.009","volume":"187","author":"QY Sun","year":"2020","unstructured":"Sun QY, Wang CE, Li YN, Bao J (2020) Inhibition of platelet aggregation and blood coagulation by a P-III class metalloproteinase purified from Naja Atra venom. Toxicon 187:223\u2013231","journal-title":"Toxicon"},{"issue":"10","key":"2013_CR36","doi-asserted-by":"publisher","first-page":"e30969","DOI":"10.1016\/j.heliyon.2024.e30969","volume":"10","author":"XJ Zhong","year":"2024","unstructured":"Zhong XJ, Wang CE, Li YN, Zhang QY, Sun QY (2024) Atrase A, a P-III class metalloproteinase purified from Cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system. Heliyon 10(10):e30969","journal-title":"Heliyon"},{"issue":"6","key":"2013_CR37","first-page":"818","volume":"20","author":"MP Sch\u00f6n","year":"2022","unstructured":"Sch\u00f6n MP (2022) The tick and I: Parasite-host interactions between ticks and humans. J Dtsch Derma Gesell 20(6):818\u2013853","journal-title":"J Dtsch Derma Gesell"},{"key":"2013_CR38","doi-asserted-by":"publisher","first-page":"139120","DOI":"10.1016\/j.ijbiomac.2024.139120","volume":"290","author":"X He","year":"2025","unstructured":"He X, Zhao Y, Guang H, Chen K, She Z, Cao M, Bai M, Yang Y et al (2025) Qinghaienin, a novel anticoagulation protein from the hard tick Haemaphysalis qinghaiensis, inhibits the activation of factor XII by competing for anionic surfaces. Int J Biol Macromol 290:139120","journal-title":"Int J Biol Macromol"},{"key":"2013_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.thromres.2017.01.012","volume":"152","author":"RK Brahma","year":"2017","unstructured":"Brahma RK, Blanchet G, Kaur S, Manjunatha Kini R, Doley R (2017) Expression and characterization of haemathrins, madanin-like thrombin inhibitors, isolated from the salivary gland of tick Haemaphysalis Bispinosa (Acari: Ixodidae). Thromb Res 152:20\u201329","journal-title":"Thromb Res"},{"issue":"1","key":"2013_CR40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ttbdis.2018.10.005","volume":"10","author":"XM He","year":"2019","unstructured":"He XM, Liu L, Cheng TY (2019) HSC70 from Haemaphysalis Flava (Acari: Ixodidae) exerts anticoagulation activity in vitro. Ticks Tick Borne Dis 10(1):170\u2013175","journal-title":"Ticks Tick Borne Dis"},{"issue":"1","key":"2013_CR41","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1038\/s41598-018-22780-1","volume":"8","author":"TC Assump\u00e7\u00e3o","year":"2018","unstructured":"Assump\u00e7\u00e3o TC, Mizurini DM, Ma D, Monteiro RQ, Ahlstedt S, Reyes M, Kotsyfakis M, Mather TN et al (2018) Ixonnexin from tick saliva promotes fibrinolysis by interacting with P lasminogen and Tissue-Type plasminogen Activator, and prevents arteria l thrombosis. Sci Rep 8(1):4806","journal-title":"Sci Rep"},{"issue":"1","key":"2013_CR42","doi-asserted-by":"publisher","first-page":"100865","DOI":"10.1016\/j.jbc.2021.100865","volume":"297","author":"SS Denisov","year":"2021","unstructured":"Denisov SS, Ippel JH, Castoldi E, Mans BJ, Hackeng TM, Dijkgraaf I (2021) Molecular basis of anticoagulant and anticomplement activity of the tick salivary protein Salp14 and its homologs. J Biol Chem 297(1):100865","journal-title":"J Biol Chem"},{"key":"2013_CR43","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ijbiomac.2019.12.189","volume":"145","author":"C Gavva","year":"2019","unstructured":"Gavva C, Patel K, Kudre T, Sharan K, Chilkunda DN (2019) Glycosaminoglycans from fresh water fish processing discard-Isolation, structural characterization, and osteogenic activity. Int J Biol Macromol 145:558\u2013567","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"2013_CR44","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00253-010-2677-1","volume":"87","author":"C Schiraldi","year":"2010","unstructured":"Schiraldi C, Cimini D, De Rosa M (2010) Production of chondroitin sulfate and chondroitin. Appl Microbiol Biotechnol 87(4):1209\u20131220","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"2013_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/13892037113149990042","volume":"14","author":"R Nasri","year":"2013","unstructured":"Nasri R, Nasri M (2013) Marine-Derived bioactive peptides as new anticoagulant agents: A review. CPPS 14(3):199\u2013204","journal-title":"CPPS"},{"key":"2013_CR46","doi-asserted-by":"publisher","first-page":"110012","DOI":"10.1016\/j.foodres.2020.110012","volume":"140","author":"HC De Moura","year":"2021","unstructured":"De Moura HC, Novello CR, Balbinot-Alfaro E, D\u00fcsman E, Barddal HPO, Almeida IV, Vicentini VEP, Prentice-Hern\u00e1ndez C et al (2021) Obtaining glycosaminoglycans from tilapia (Oreochromis niloticus) scales and evaluation of its anticoagulant and cytotoxic activities: glycosaminoglycans from tilapia scales: anticoagulant and cytotoxic activities. Food Res Int 140:110012","journal-title":"Food Res Int"},{"key":"2013_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijbiomac.2018.09.156","volume":"121","author":"AV Nogueira","year":"2019","unstructured":"Nogueira AV, Rossi GR, Iacomini M, Sassaki GL, Trindade ES, Cipriani TR (2019) Viscera of fishes as Raw material for extraction of glycosaminoglycans of Pharmacological interest. Int J Biol Macromol 121:239\u2013248","journal-title":"Int J Biol Macromol"},{"key":"2013_CR48","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ijbiomac.2022.05.001","volume":"210","author":"FK Dong","year":"2022","unstructured":"Dong FK, Quan XG, Wang QB, Liu ZM, Cui T, Wang WJ, Tang DM, Zhang RM et al (2022) Purification, structural characterization, and anticoagulant activity evaluation of chondroitin sulfate from codfish (Gadus macrocephalus) bones. Int J Biol Macromol 210:759\u2013767","journal-title":"Int J Biol Macromol"},{"issue":"66","key":"2013_CR49","doi-asserted-by":"publisher","first-page":"37965","DOI":"10.1039\/C8RA06704J","volume":"8","author":"F Krichen","year":"2018","unstructured":"Krichen F, Bougatef H, Capitani F, Ben Amor I, Koubaa I, Gargouri J, Maccari F, Mantovani V et al (2018) Purification and structural Elucidation of chondroitin sulfate\/dermatan sulfate from Atlantic Bluefin tuna (Thunnus thynnus) skins an d their anticoagulant and ACE inhibitory activities. RSC Adv 8(66):37965\u201337975","journal-title":"RSC Adv"},{"key":"2013_CR50","doi-asserted-by":"publisher","first-page":"116566","DOI":"10.1016\/j.foodres.2025.116566","volume":"213","author":"Z Yang","year":"2025","unstructured":"Yang Z, Xu H, Wang C, Liu Z, Chen Y, Zhao C, Chen J (2025) Discovery and mechanism of novel anticoagulant peptides from Larimichthys Crocea based on in silico, molecular docking, molecular dynamics, and in vitro analysis. Food Res Int 213:116566","journal-title":"Food Res Int"},{"issue":"2","key":"2013_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/md19020116","volume":"19","author":"D Coppola","year":"2021","unstructured":"Coppola D, Lauritano C, Palma Esposito F, Riccio G, Rizzo C, de Pascale D (2021) Fish waste: from problem to valuable resource. Mar Drugs 19(2):116","journal-title":"Mar Drugs"},{"issue":"1","key":"2013_CR52","first-page":"252","volume":"50","author":"Q Liu","year":"2019","unstructured":"Liu Q, Bi QR, Tan NH (2019) Research progress on proteins and peptides from earthworm. Chin Trad Herb Drugs 50(1):252\u2013261","journal-title":"Chin Trad Herb Drugs"},{"key":"2013_CR53","doi-asserted-by":"crossref","unstructured":"Mustafa RG, Dr Saiqa A, Dom\u00ednguez J, Jamil M, Manzoor S, Wazir S, Shaheen B, Parveen A et al (2022) Therapeutic Values of Earthworm Species Extract from Azad Kashmir as Anticoagulant, Antibacterial, and Antioxidant Agents. Can J Infect Diseases and Med Microbiol 2022: 1\u201320","DOI":"10.1155\/2022\/6949117"},{"key":"2013_CR54","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbrc.2022.03.005","volume":"603","author":"L Ding","year":"2022","unstructured":"Ding L, Shu Z, Hao J, Luo X, Ye X, Zhu W, Duan W, Chen Z (2022) Schixator, a new FXa inhibitor from Schistosoma Japonicum with antithrombotic effect and low bleeding risk. Biochem Biophys Res Commun 603:138\u2013143","journal-title":"Biochem Biophys Res Commun"},{"key":"2013_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fct.2017.08.026","volume":"109","author":"W Lee","year":"2017","unstructured":"Lee W, Kim MA, Park I, Hwang JS, Na M, Bae JS (2017) Novel direct factor Xa inhibitory compounds from Tenebrio molitor with anti-platelet aggregation activity. Food Chem Toxicol 109:19\u201327","journal-title":"Food Chem Toxicol"},{"key":"2013_CR56","doi-asserted-by":"publisher","first-page":"116179","DOI":"10.1016\/j.ejmech.2024.116179","volume":"267","author":"AK Yadav","year":"2024","unstructured":"Yadav AK, Maharjan Shrestha R, Yadav PN (2024) Anticancer mechanism of coumarin-based derivatives. Eur J Med Chem 267:116179","journal-title":"Eur J Med Chem"},{"issue":"2","key":"2013_CR57","doi-asserted-by":"publisher","first-page":"102922","DOI":"10.1016\/j.arabjc.2020.102922","volume":"14","author":"C Ranjan Sahoo","year":"2021","unstructured":"Ranjan Sahoo C, Sahoo J, Mahapatra M, Lenka D, Kumar Sahu P, Dehury B, Nath Padhy R, Kumar Paidesetty S (2021) Coumarin derivatives as promising antibacterial agent(s). Arab J Chem 14(2):102922","journal-title":"Arab J Chem"},{"issue":"7","key":"2013_CR58","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1007\/s00044-012-0321-6","volume":"22","author":"Y Bansal","year":"2013","unstructured":"Bansal Y, Sethi P, Bansal G (2013) Coumarin: a potential nucleus for anti-inflammatory molecules. Med Chem Res 22(7):3049\u20133060","journal-title":"Med Chem Res"},{"key":"2013_CR59","doi-asserted-by":"crossref","unstructured":"Kadhum AAH, Al-Amiery AA, Musa AY, Mohamad AB (2011) The Antioxidant Activity of New Coumarin Derivatives. IJMS 12(9): 5747\u20135761","DOI":"10.3390\/ijms12095747"},{"issue":"11","key":"2013_CR60","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s00044-023-03148-1","volume":"32","author":"TM Ramsis","year":"2023","unstructured":"Ramsis TM, Ebrahim MA, Fayed EA (2023) Synthetic coumarin derivatives with anticoagulation and antiplatelet aggregation inhibitory effects. Med Chem Res 32(11):2269\u20132278","journal-title":"Med Chem Res"},{"key":"2013_CR61","doi-asserted-by":"publisher","first-page":"104947","DOI":"10.1016\/j.fitote.2021.104947","volume":"154","author":"L Gao","year":"2021","unstructured":"Gao L, Wang F, Chen Y, Li F, Han B, Liu D (2021) The antithrombotic activity of natural and synthetic coumarins. Fitoterapia 154:104947","journal-title":"Fitoterapia"},{"key":"2013_CR62","doi-asserted-by":"publisher","first-page":"153987","DOI":"10.1016\/j.phymed.2022.153987","volume":"99","author":"N Kim","year":"2022","unstructured":"Kim N, Jeon C, Kim C, Ryu SH, Lee W, Bae JS (2022) Inhibition of factor Xa activity, platelet aggregation, and experimentally induced thrombosis by Sparstolonin B. Phytomedicine 99:153987","journal-title":"Phytomedicine"},{"issue":"1","key":"2013_CR63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1076029615595879","volume":"23","author":"A Mira","year":"2017","unstructured":"Mira A, Alkhiary W, Shimizu K (2017) Antiplatelet and anticoagulant activities of Angelica Shikokiana extract and its isolated compounds. Clin Appl Thromb Hemost 23(1):91\u201399","journal-title":"Clin Appl Thromb Hemost"},{"key":"2013_CR64","doi-asserted-by":"publisher","first-page":"102181","DOI":"10.1016\/j.rechem.2025.102181","volume":"15","author":"I Tchoffo Tchoupou","year":"2025","unstructured":"Tchoffo Tchoupou I, Manyeruke MH, Salami SA, Ezekiel CI, Ambassa P, Tembu JV, Krause RWM, Ngameni B et al (2025) An overview of the synthesis of coumarins via Knoevenagel condensation and their biological properties. Results Chem 15:102181","journal-title":"Results Chem"},{"issue":"12","key":"2013_CR65","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1007\/s11172-023-4099-0","volume":"72","author":"AA Skoptsova","year":"2023","unstructured":"Skoptsova AA, Novichikhina NP, Kosheleva EA, Krysin MY, Baranin SV, Shikhaliev KS (2023) New hybrid compounds bearing Pyrrolo [3,2,1-ij] quinolin-2-one and coumarin motifs. Synthesis and evaluation of anticoagulant activity. Russ Chem Bull 72(12):2898\u20132907","journal-title":"Russ Chem Bull"},{"issue":"5","key":"2013_CR66","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11094-019-02013-z","volume":"53","author":"NC Bang","year":"2019","unstructured":"Bang NC, Abyshev AZ, Ivkin DY (2019) Synthesis and in vivo evaluation of new coumarin conjugates as potential indirect-Action anticoagulants. Pharm Chem J 53(5):419\u2013422","journal-title":"Pharm Chem J"},{"key":"2013_CR67","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijbiomac.2018.07.048","volume":"119","author":"I Ahmad","year":"2018","unstructured":"Ahmad I, Sharma S, Gupta N, Rashid Q, Abid M, Ashraf MZ, Jairajpuri MA (2018) Antithrombotic potential of Esculin 7, 3\u2032, 4\u2032, 5\u2032, 6\u2032-O-pentasulfate(EPS) for its role in thrombus reduction using rat thrombosis model. Int J Biol Macromol 119:360\u2013368","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"2013_CR68","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2174\/1573406412666160129105115","volume":"12","author":"AV Lipeeva","year":"2016","unstructured":"Lipeeva AV, Khvostov MV, Baev DS, Shakirov MM, Tolstikova TG, Shults EE (2016) Synthesis, in vivo anticoagulant evaluation and molecular Docking studies of bicoumarins obtained from furocoumarin Peucedanin. Med Chem 12(7):674\u2013683","journal-title":"Med Chem"},{"issue":"3","key":"2013_CR69","first-page":"330","volume":"43","author":"Z Afzal","year":"2021","unstructured":"Afzal Z, Rashid N, Nadeem H (2021) Stereoselective synthesis, spectral characterization, Docking and biological screening of coumarin derivatives. J Chem Soc Pak 43(3):330\u2013341","journal-title":"J Chem Soc Pak"},{"issue":"4","key":"2013_CR70","first-page":"643","volume":"15","author":"I Mazreku","year":"2022","unstructured":"Mazreku I, Rudhani I, Lajqi L, Hadergjonaj M, Ibrahimi H, Haziri A (2022) Some experimental studies on the anticoagulant activity of the synthetic coumarin derivatives. J Biol Sci 15(4):643\u2013647","journal-title":"J Biol Sci"},{"key":"2013_CR71","first-page":"137049","volume":"1298","author":"\u017d Milanovi\u0107","year":"2024","unstructured":"Milanovi\u0107 \u017d (2024) Structural properties of newly 4,7-dihydroxycoumarin derivatives as potential inhibitors of XIIa, Xa, IIa factors of coagulation. JMoSt 1298:137049","journal-title":"JMoSt"},{"key":"2013_CR72","doi-asserted-by":"crossref","unstructured":"Ren C, Qian J, Wang Y, Xie L, Guo Y, Chen K, Li X (2024) Flavonoid UDP-glycosyltransferase in plants: functional identification, substrate recognition mechanism, and biotechnology application. Phytochem Rev: 1\u201324","DOI":"10.1007\/s11101-024-10042-0"},{"issue":"9","key":"2013_CR73","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3390\/molecules27092901","volume":"27","author":"JM Al Khayri","year":"2022","unstructured":"Al Khayri JM, Sahana GR, Nagella P, Joseph BV, Alessa FM, Al Mssallem MQ (2022) Flavonoids as potential Anti-Inflammatory molecules: A review. Molecules 27(9):2901","journal-title":"Molecules"},{"key":"2013_CR74","doi-asserted-by":"publisher","first-page":"132531","DOI":"10.1016\/j.foodchem.2022.132531","volume":"383","author":"N Shen","year":"2022","unstructured":"Shen N, Wang T, Gan Q, Liu S, Wang L, Jin B (2022) Plant flavonoids: Classification, distribution, biosynthesis, and anti oxidant activity. Food Chem 383:132531","journal-title":"Food Chem"},{"issue":"1","key":"2013_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.22159\/ijap.2021.v13s1.Y0050","volume":"13","author":"P Pouyfung","year":"2021","unstructured":"Pouyfung P, Sukati S (2021) Anticoagulation properties of flavonoids: potential structure-function relationships. Int J App Pharm 13(1):9\u201312","journal-title":"Int J App Pharm"},{"issue":"6","key":"2013_CR76","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/14786419.2017.1332603","volume":"32","author":"JL Lv","year":"2018","unstructured":"Lv JL, Li ZZ, Zhang LB (2018) Two new flavonoids from Artemisia argyi with their anticoagulation activities. Nat Prod Res 32(6):632\u2013639","journal-title":"Nat Prod Res"},{"key":"2013_CR77","doi-asserted-by":"publisher","first-page":"118686","DOI":"10.1016\/j.jep.2024.118686","volume":"335","author":"D Gogoi","year":"2024","unstructured":"Gogoi D, Chattopadhyay P, Dolui SK, Khan MR, Mukherjee AK (2024) Studies on in vivo antithrombotic activity of quercetin, a natural flavonoid isolated from a traditional medicinal plant, African eggplant (Solanum indicum). J Ethnopharmacol 335:118686","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"2013_CR78","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/ph16040588","volume":"16","author":"GO Kim","year":"2023","unstructured":"Kim GO, Heo JB, Park DH, Song GY, Bae JS (2023) Antiplatelet aggregation properties of cirsilineol: A novel inhibitor of blood coagulation factor Xa. Pharmaceuticals 16(4):588","journal-title":"Pharmaceuticals"},{"key":"2013_CR79","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.indcrop.2018.12.036","volume":"129","author":"N He","year":"2019","unstructured":"He N, Wang P, Niu Y, Chen J, Li C, Kang W (2019) Evaluation antithrombotic activity and action mechanism of myricitrin. Ind Crops Prod 129:536\u2013541","journal-title":"Ind Crops Prod"},{"key":"2013_CR80","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ijbiomac.2019.04.181","volume":"134","author":"LH Wei","year":"2019","unstructured":"Wei LH, Chen TR, Fang HB, Jin Q, Zhang SJ, Hou J, Yu Y, Dou TY et al (2019) Natural constituents of St. John\u2019s wort inhibit the proteolytic activity of human thrombin. Int J Biol Macromol 134:622\u2013630","journal-title":"Int J Biol Macromol"},{"key":"2013_CR81","doi-asserted-by":"publisher","first-page":"103199","DOI":"10.1016\/j.bioorg.2019.103199","volume":"92","author":"TR Chen","year":"2019","unstructured":"Chen TR, Wei LH, Guan XQ, Huang C, Liu ZY, Wang FJ, Hou J, Jin Q et al (2019) Biflavones from Ginkgo Biloba as inhibitors of human thrombin. Bioorg Chem 92:103199","journal-title":"Bioorg Chem"},{"key":"2013_CR82","doi-asserted-by":"publisher","first-page":"116030","DOI":"10.1016\/j.indcrop.2022.116030","volume":"192","author":"HL Le","year":"2023","unstructured":"Le HL, Nguyen VH, Nguyen TD, Nguyen TVA, Le DH (2023) Potential antiaggregatory and anticoagulant activity of Kaempferia parviflora extract and its methoxyflavones. Ind Crops Prod 192:116030","journal-title":"Ind Crops Prod"},{"key":"2013_CR83","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.talanta.2018.03.049","volume":"185","author":"QQ Li","year":"2018","unstructured":"Li QQ, Yang FQ, Wang YZ, Wu ZY, Xia ZN, Chen H (2018) Evaluation of thrombin inhibitory activity of catechins by online capillary electrophoresis-based immobilized enzyme microreactor and molecular Docking. Talanta 185:16\u201322","journal-title":"Talanta"},{"key":"2013_CR84","first-page":"1407","volume":"48","author":"A Rajput","year":"2022","unstructured":"Rajput A, Sharma R, Bharti R (2022) Pharmacological activities and toxicities of alkaloids on human health. Mater Today 48:1407\u20131415","journal-title":"Mater Today"},{"issue":"3","key":"2013_CR85","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/molecules27030903","volume":"27","author":"FL Abookleesh","year":"2022","unstructured":"Abookleesh FL, Al-Anzi BS, Ullah A (2022) Potential antiviral action of alkaloids. Molecules 27(3):903","journal-title":"Molecules"},{"issue":"3","key":"2013_CR86","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/antibiotics10030318","volume":"10","author":"Y Yan","year":"2021","unstructured":"Yan Y, Li X, Zhang C, Lv L, Gao B, Li M (2021) Research progress on antibacterial activities and mechanisms of natural alkaloids: A review. Antibiot (Basel) 10(3):318","journal-title":"Antibiot (Basel)"},{"issue":"2","key":"2013_CR87","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1570180813666160712224752","volume":"14","author":"BSP Marya","year":"2017","unstructured":"Marya BSP, Khan H (2017) Anti-inflammatory potential of alkaloids as a promising therapeutic modality. LDDD 14(2):240\u2013249","journal-title":"LDDD"},{"key":"2013_CR88","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fphar.2016.00292","volume":"7","author":"QU Ain","year":"2016","unstructured":"Ain QU, Khan H, Mubarak MS, Pervaiz A (2016) Plant alkaloids as antiplatelet agent: drugs of the future in the light of recent developments. Front Pharmacol 7:292","journal-title":"Front Pharmacol"},{"issue":"13","key":"2013_CR89","first-page":"2192","volume":"13","author":"KP Huang","year":"2023","unstructured":"Huang KP, Xu LL, Li S, Wei YL, Yang L, Hao XJ, He HP, Zhang Y (2023) Correction: uncarialines A-E, new alkaloids from Uncaria rhynchophylla and their anticoagulant activity. Nat Prod Bio 13(13):2192\u20132195","journal-title":"Nat Prod Bio"},{"key":"2013_CR90","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.yrtph.2018.03.004","volume":"95","author":"S Chang","year":"2018","unstructured":"Chang S, Yang Z, Han N, Liu Z, Yin J (2018) The antithrombotic, anticoagulant activity and toxicity research of ambinine, an alkaloid from the tuber of Corydalis Ambigua var. Amurensis. Regul Toxicol Pharmacol 95:175\u2013181","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"2013_CR91","doi-asserted-by":"publisher","first-page":"21956","DOI":"10.1038\/srep21956","volume":"6","author":"W Lee","year":"2016","unstructured":"Lee W, Lee J, Kulkarni R, Kim M, Hwang JS, Na M, Bae J (2016) Antithrombotic and antiplatelet activities of small-molecule alkaloids from Scolopendra subspinipes mutilans. Sci Rep 6(1):21956","journal-title":"Sci Rep"},{"issue":"9","key":"2013_CR92","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1134\/S1070428022090056","volume":"58","author":"NP Novichikhina","year":"2022","unstructured":"Novichikhina NP, Ashrafova ZE, Ledenyova IV, Podoplelova NA, Panteleev MA, Shikhaliev KS (2022) Synthesis and anticoagulant activity of new functionalized 4H-Pyrrolo [3,2,1-ij] quinolin-2-ones. Russ J Org Chem 58(9):1225\u20131232","journal-title":"Russ J Org Chem"},{"issue":"9","key":"2013_CR93","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s11172-022-3615-y","volume":"71","author":"NP Novichikhina","year":"2022","unstructured":"Novichikhina NP, Ashrafova ZE, Stolpovskaya NV, Ledenyova IV, Kholyavka MG, Podoplelova NA, Panteleev MA, Shikhaliev KS (2022) Synthesis and properties of novel hybrid molecules bearing 4H-pyrrolo [3,2,1-ij] quinolin-2-one and thiazole moieties. Russ Chem Bull 71(9):1969\u20131975","journal-title":"Russ Chem Bull"},{"issue":"9","key":"2013_CR94","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.3390\/molecules28093851","volume":"28","author":"NP Novichikhina","year":"2023","unstructured":"Novichikhina NP, Shestakov AS, Medvedeva SM, Lagutina AM, Krysin MY, Podoplelova NA, Panteleev MA, Ilin IS et al (2023) New hybrid Tetrahydropyrrolo [3,2,1-ij] quinolin-1-ylidene-2-thioxothiaz olidin-4-ones as new inhibitors of factor Xa and factor xia: Design, Synthesis, and in Silico and experimental evaluation. Molecules 28(9):3851","journal-title":"Molecules"},{"issue":"5","key":"2013_CR95","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s10593-021-02945-z","volume":"57","author":"AY Potapov","year":"2021","unstructured":"Potapov AY, Paponov BV, Podoplelova NA, Panteleev MA, Potapov MA, Ledenyova IV, Stolpovskaya NV, Shikhaliev KS (2021) Synthesis of 2H-pyrano [3,2-g] quinolin-2-ones containing a pyrimidinone moiety and characterization of their anticoagulant activity via Inhibition of blood coagulation factors Xa and XIa. Chem Heterocycl Comp 57(5):574\u2013580","journal-title":"Chem Heterocycl Comp"},{"issue":"3","key":"2013_CR96","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11172-021-3114-6","volume":"70","author":"AY Potapov","year":"2021","unstructured":"Potapov AY, Paponov BV, Podoplelova NA, Panteleev MA, Polikarchuk VA, Ledenyova IV, Stolpovskaya NV, Kryl\u2019skii DV et al (2021) Synthesis and study of new 2H-pyranoquinolin-2-one-based inhibitors of blood coagulation factors Xa and XIa. Russ Chem Bull 70(3):492\u2013497","journal-title":"Russ Chem Bull"},{"issue":"1","key":"2013_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00425-018-3056-x","volume":"249","author":"SD Tetali","year":"2019","unstructured":"Tetali SD (2019) Terpenes and isoprenoids: a wealth of compounds for global use. Planta 249(1):1\u20138","journal-title":"Planta"},{"issue":"9\u201310","key":"2013_CR98","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10495-021-01684-y","volume":"26","author":"C El Baba","year":"2021","unstructured":"El Baba C, Baassiri A, Kiriako G, Dia B, Fadlallah S, Moodad S, Darwiche N (2021) Terpenoids\u2019 anti-cancer effects: focus on autophagy. Apoptosis 26(9\u201310):491\u2013511","journal-title":"Apoptosis"},{"issue":"8","key":"2013_CR99","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00203-022-03142-y","volume":"204","author":"T Yamaguchi","year":"2022","unstructured":"Yamaguchi T (2022) Antibacterial effect of the combination of terpenoids. Arch Microbiol 204(8):520","journal-title":"Arch Microbiol"},{"issue":"31","key":"2013_CR100","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.2174\/092986712803833335","volume":"19","author":"E Gonzalez-Burgos","year":"2012","unstructured":"Gonzalez-Burgos E, Gomez-Serranillos MP (2012) Terpene compounds in nature: A review of their potential antioxidant A Ctivity. CMC 19(31):5319\u20135341","journal-title":"CMC"},{"key":"2013_CR101","doi-asserted-by":"publisher","first-page":"107697","DOI":"10.1016\/j.pharmthera.2020.107697","volume":"216","author":"J Yang","year":"2020","unstructured":"Yang J, He Y, Li Y, Zhang X, Wong Y-K, Shen S, Zhong T, Zhang J et al (2020) Advances in the research on the targets of anti-malaria actions of Art Emisinin. Pharmacol Ther 216:107697","journal-title":"Pharmacol Ther"},{"issue":"27","key":"2013_CR102","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.2174\/0929867325666180214110932","volume":"25","author":"SB Ateba","year":"2018","unstructured":"Ateba SB, Mvondo MA, Ngeu ST, Tchoumtchoua J, Awounfack CF, Njamen D, Krenn L (2018) Natural terpenoids against female breast cancer: A 5-year recent research. CMC 25(27):3162\u20133213","journal-title":"CMC"},{"key":"2013_CR103","doi-asserted-by":"publisher","first-page":"105198","DOI":"10.1016\/j.fitote.2022.105198","volume":"159","author":"Y Yu","year":"2022","unstructured":"Yu Y, Sun XY, Xu KL, Ma J, Zang YD, Hou Q, Peng Y, Li CJ et al (2022) Meroterpenoids with unknown skeletons from the leaves of Psidium Guajava including one anti-inflammatory and anticoagulant compound: Psidial F. Fitoterapia 159:105198","journal-title":"Fitoterapia"},{"issue":"35","key":"2013_CR104","doi-asserted-by":"publisher","first-page":"25579","DOI":"10.1039\/D4RA04709E","volume":"14","author":"JG De Luna","year":"2024","unstructured":"De Luna JG, Gonzales SCB, Nuqui JJM, Capinding ES, Sacdalan CD (2024) Docking-based computational analysis of guava (Psidium guajava) leaves derived bioactive compounds as a coagulation factor IXa inhibi Tor. RSC Adv 14(35):25579\u201325585","journal-title":"RSC Adv"},{"key":"2013_CR105","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jff.2014.11.012","volume":"12","author":"LZ Li","year":"2015","unstructured":"Li LZ, Gao PY, Song SJ, Yuan YQ, Liu CT, Huang XX, Liu QB (2015) Monoterpenes and flavones from the leaves of Crataegus pinnatifida with anticoagulant activities. J Funct Foods 12:237\u2013245","journal-title":"J Funct Foods"},{"issue":"11","key":"2013_CR106","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1021\/acs.jnatprod.8b00574","volume":"81","author":"D Gogoi","year":"2018","unstructured":"Gogoi D, Pal A, Chattopadhyay P, Paul S, Deka RC, Mukherjee AK (2018) First report of Plant-Derived \u03b2-Sitosterol with Antithrombotic, in vivo Anticoagulant, and thrombus preventing activities in a mouse model. J Nat Prod 81(11):2521\u20132530","journal-title":"J Nat Prod"},{"issue":"4","key":"2013_CR107","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/molecules22040649","volume":"22","author":"L Xiong","year":"2017","unstructured":"Xiong L, Qi Z, Zheng B, Li Z, Wang F, Liu J, Li P (2017) Inhibitory effect of triterpenoids from Panax ginseng on coagulation factor X. Molecules 22(4):649","journal-title":"Molecules"},{"key":"2013_CR108","doi-asserted-by":"publisher","first-page":"105833","DOI":"10.1016\/j.fitote.2024.105833","volume":"174","author":"W Nie","year":"2024","unstructured":"Nie W, Zhang HY, Ma YX, Wan JF, Feng LPC, Tao Li Q (2024) New steroidal saponins from the aerial parts of Paris polyphylla var. Yunnanensis and their effects on blood coagulation. Fitoterapia 174:105833\u2013105833","journal-title":"Fitoterapia"},{"key":"2013_CR109","doi-asserted-by":"publisher","first-page":"104345","DOI":"10.1016\/j.fitote.2019.104345","volume":"138","author":"XL Ouyang","year":"2019","unstructured":"Ouyang XL, Mao WH, Wang CG, Pan YM, Liang DW, Heng S (2019) Five 11\u03b1, 12\u03b1-epoxy pentacyclic triterpenoid saponins with antithrombus activities from Glechoma longituba. Fitoterapia 138:104345","journal-title":"Fitoterapia"},{"issue":"23","key":"2013_CR110","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1016\/j.bmcl.2018.05.036","volume":"28","author":"J Wang","year":"2018","unstructured":"Wang J, Ma H, Fu H (2018) Semisynthesis of ent-norstrobane diterpenoids as potential inhibitor for factor Xa. Bioorg Med Chem Lett 28(23):3813\u20133815","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"2013_CR111","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.bmc.2019.02.032","volume":"27","author":"J Wang","year":"2019","unstructured":"Wang J, Wu M, Gao C, Fu H (2019) Semisynthesis of epoxy-pimarane diterpenoids from kirenol and their FXa Inhibition activities. Bioorg Med Chem 27(7):1320\u20131326","journal-title":"Bioorg Med Chem"},{"key":"2013_CR112","doi-asserted-by":"publisher","first-page":"111722","DOI":"10.1016\/j.ejmech.2019.111722","volume":"183","author":"P Chen","year":"2019","unstructured":"Chen P, Zhang D, Li M, Wu Q, Lam YPY, Guo Y, Chen C, Bai N et al (2019) Discovery of novel, potent, isosteviol-based antithrombotic agents. Eur J Med Chem 183:111722","journal-title":"Eur J Med Chem"},{"issue":"2","key":"2013_CR113","doi-asserted-by":"publisher","first-page":"126585","DOI":"10.1016\/j.bmcl.2019.07.044","volume":"30","author":"Y Shi","year":"2020","unstructured":"Shi Y, Pan BW, Li WC, Wang Q, Wu Q, Pan M, Fu HZ (2020) Synthesis and biological evaluation of isosteviol derivatives as FXa inhibitors. Bioorg Med Chem Lett 30(2):126585","journal-title":"Bioorg Med Chem Lett"},{"key":"2013_CR114","doi-asserted-by":"publisher","first-page":"112025","DOI":"10.1016\/j.phytochem.2019.04.018","volume":"165","author":"X Yu","year":"2019","unstructured":"Yu X, Wei LH, Zhang JK, Chen TR, Jin Q, Wang YN, Zhang SJ, Dou TY et al (2019) Anthraquinones from Cassiae semen as thrombin inhibitors: in vitro and in Silico studies. Phytochemistry 165:112025","journal-title":"Phytochemistry"},{"key":"2013_CR115","doi-asserted-by":"publisher","first-page":"112475","DOI":"10.1016\/j.jep.2019.112475","volume":"252","author":"T Khouya","year":"2020","unstructured":"Khouya T, Ramchoun M, Amrani S, Harnafi H, Rouis M, Couchie D, Simmet T, Alem C (2020) Anti-inflammatory and anticoagulant effects of polyphenol-rich extracts from Thymus atlanticus: an in vitro and in vivo study. J Ethnopharmacol 252:112475","journal-title":"J Ethnopharmacol"},{"key":"2013_CR116","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.fct.2017.04.012","volume":"105","author":"W Lee","year":"2017","unstructured":"Lee W, Ku SK, Kim MA, Bae JS (2017) Anti-factor Xa activities of Zingerone with anti-platelet aggregation activity. Food Chem Toxicol 105:186\u2013193","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"2013_CR117","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jfutfo.2023.07.006","volume":"4","author":"C Ma","year":"2024","unstructured":"Ma C, Chen S, Rizvi SAH, Zhou H, Kang W, Xi X, Liu Z (2024) Chemical constituents and anticoagulant activity from Delphinium brunonianum royle. J Future Foods 4(3):241\u2013247","journal-title":"J Future Foods"},{"key":"2013_CR118","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.sajb.2022.03.035","volume":"147","author":"HL Le","year":"2022","unstructured":"Le HL, Nguyen TMH, Vu TT, Nguyen TTO, Ly HDT, Le NT, Nguyen VH, Nguyen TVA (2022) Potent antiplatelet aggregation, anticoagulant and antioxidant activity of aerial Canna x generalis L.H Bailey & E.Z Bailey and its phytoconstituents. S Afr Jf Bot 147:882\u2013893","journal-title":"S Afr Jf Bot"},{"issue":"3","key":"2013_CR119","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCRESAHA.118.313155","volume":"124","author":"NC Chan","year":"2019","unstructured":"Chan NC, Weitz JI (2019) Antithrombotic agents. Circ Res 124(3):426\u2013436","journal-title":"Circ Res"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-026-02013-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-026-02013-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-026-02013-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:02:33Z","timestamp":1779206553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-026-02013-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2013"],"URL":"https:\/\/doi.org\/10.1007\/s11418-026-02013-w","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}